eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | retinal vein occlusion |
| Comorbidity | C0271051|macular oedema |
| Sentences | 32 |
| PubMedID- 26533906 | Challenges to the economic modelling of macular oedema due to retinal vein occlusion and diabetes. |
| PubMedID- 20111061 | Purpose: to investigate whether interleukine-8 (il-8) and monocyte chemoattractant protein-1 (mcp-1) are related with macular oedema in patients with branch retinal vein occlusions (brvos). |
| PubMedID- 20339391 | Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. |
| PubMedID- 21155986 | Purpose: to investigate the correlation between integrity of foveal photoreceptor layer and initial as well as final visual acuity (va) after successful resolution of macular oedema (me) associated with retinal vein occlusion (rvo). |
| PubMedID- 24513867 | Antithrombotics, such as low-molecular weight heparin (lmwh), and fibrinolytics have also been found to benefit visual acuity in retinal vein occlusion with no associated macular oedema. |
| PubMedID- 23153657 | Grid laser photocoagulation for macular oedema due to branch retinal vein occlusion in the age of bevacizumab. |
| PubMedID- 25777815 | Background/aims: to compare the functional and anatomical outcomes of intravitreal bevacizumab (ivb) with those of dexamethasone implant injection (ivd) for macular oedema associated with branch retinal vein occlusion (brvo). |
| PubMedID- 25631483 | Purpose: to assess the efficacy and safety of intravitreal bevacizumab (ivb) compared with ranibizumab (ivr) in the treatment of macular oedema due to branch retinal vein occlusion (brvo). |
| PubMedID- 22653519 | Purpose: to study the relationship between macular ischaemia on fluorescein angiography (fa) and pathomorphology at the foveal centre delineated by spectral-domain optical coherence tomography (oct) in macular oedema (mo) associated with branch retinal vein occlusion (brvo). |
| PubMedID- 21947148 | Branch retinal vein occlusion with macular oedema is an additional finding in our study, which has not been previously reported. |
| PubMedID- 25989706 | Purpose: to investigate whether targeted retinal photocoagulation (trp) of peripheral non-perfused areas (npas) could prevent the recurrence of macular oedema (me) due to branch retinal vein occlusion (brvo) after intravitreal bevacizumab injection (ivb). |
| PubMedID- 20456252 | Purpose: to determine the aqueous humour levels of chemokines before and after an intravitreal injection of triamcinolone acetonide (ivta) in eyes with macular oedema associated with a branch retinal vein occlusion (me-brvo). |
| PubMedID- 22863290 | Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion. |
| PubMedID- 23712192 | Prospective pilot study: efficacy of intravitreal dexamethasone and bevacizumab injections in the treatment of macular oedema associated with branch retinal vein occlusion. |
| PubMedID- 25619682 | Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study. |
| PubMedID- 20494908 | Purpose: to evaluate the efficacy and safety of simultaneous intravitreal injection of triamcinolone acetonide (ta) and tissue plasminogen activator (tpa) for macular oedema associated with central retinal vein occlusion (crvo). |
| PubMedID- 20679089 | Background: the purpose of this study is to evaluate the efficacy of intravitreal bevacizumab as the primary treatment of macular oedema due to retinal vein occlusions. |
| PubMedID- 23077221 | Association of electroretinographic parameters and inflammatory factors in branch retinal vein occlusion with macular oedema. |
| PubMedID- 25138756 | Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion. |
| PubMedID- 21913147 | [new developments in the pharmacological treatment of macular oedema due to retinal vein occlusion]. |
| PubMedID- 26149584 | Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study. |
| PubMedID- 21109696 | Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion. |
| PubMedID- 26197958 | [comparison of intravitreal dexamethasone implant versus intravitreal ranibizumab as a first-line treatment of macular oedema due to retinal vein occlusion]. |
| PubMedID- 25503473 | Purpose: to retrospectively evaluate the re-injection interval, efficacy and safety of dexamethasone (dex) intravitreal implant 0.7 mg in the treatment of macular oedema (me) due to retinal vein occlusion (rvo) in germany in 2009-2012. |
| PubMedID- 22833773 | Perifoveal microcirculation in macular oedema with retinal vein occlusion. |
| PubMedID- 21751750 | macular oedema is one of the complications of retinal vein occlusion. |
| PubMedID- 19563372 | Purpose: this study aimed to investigate whether vascular endothelial growth factor (vegf) or interleukin-6 (il-6) influence macular oedema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 22132711 | Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion. |
| PubMedID- 23016250 | In practice, the decision to grant marketing authorisation for ranibizumab in macular oedema due to retinal vein occlusion was premature. |
| PubMedID- 19696805 | Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. |
| PubMedID- 26395854 | [treatment of macular oedema due to retinal vein occlusion with ozurdex]. |
| PubMedID- 22415022 | Vascular endothelial growth factor receptor-2 in macular oedema with retinal vein occlusion. |
Page: 1